FC-GAMMA RECEPTOR-MEDIATED BIOLOGICAL-ACTIVITIES OF HUMAN LEUKEMIC-CELL LINES AND THEIR MODULATION BY TRANSFORMING GROWTH-FACTOR-BETA-1 AND INTERLEUKIN-6

被引:5
作者
MORIKAWA, M
HARADA, N
NUNOMURA, Y
KOIKE, T
HASHIMOTO, S
SOMA, G
YOSHIDA, T
机构
[1] Tokyo Institute for Immunopharmacology, Inc., Chugai Pharmaceutical Co., Ltd., Toshima-ku, Tokyo, 171
关键词
TGF-BETA-1; IL-6; FC-GAMMA RECEPTOR; HUMAN LEUKEMIC CELL LINES; ADCC; ACTIVE OXYGEN MOLECULES;
D O I
10.1016/1043-4666(93)90013-U
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously we reported that transforming growth factor-β1 (TGF-β1) remarkably enhanced the differentiation of human leukemic cell lines, HL-60 and THP-1, in the presence of 1α,25-dihydroxyvitamin D3 (VD3) and also that it induced Fc receptor for immunoglobulin G (FcγR), type IIIB, in the presence of retinoic acid (RA). The present study revealed that TGF-β1 enhanced the FcγRI- and FcγRII-mediated antibody-dependent cellular cytotoxicity (ADCC) of the cells differentiated in the presence of VD3 and RA. However, production of active oxygen molecules was suppressed by TGF-β1. On the other hand, IL-6 stimulated production of active oxygen molecules and ADCC of the cells treated with VD3 and tumor necrosis factor-α (TNF-α). Furthermore, the levels of cell surface FcγRI and FcγRII were not clearly correlated with the ADCC. The TGF-β1 VD3-treated HL-60 cells were able to synthesize mRNAs for TGF-β1 and TNF-α, although TNF-α protein was not detectable. These results suggest that TGF-β1 has a bifunctional role, either stimulatory or inhibitory, in the modulation of macrophage activities through FcγRs and that IL-6 stimulates certain macrophage activities in mature cells. © 1993.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 28 条
[1]   EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES [J].
ASSOIAN, RK ;
FLEURDELYS, BE ;
STEVENSON, HC ;
MILLER, PJ ;
MADTES, DK ;
RAINES, EW ;
ROSS, R ;
SPORN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6020-6024
[2]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].
BREITMAN, TR ;
SELONICK, SE ;
COLLINS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940
[3]  
CHERVENICK PA, 1988, ATLAS BLOOD CELLS, V1, P1
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]   HUMAN TRANSFORMING GROWTH FACTOR-BETA COMPLEMENTARY-DNA SEQUENCE AND EXPRESSION IN NORMAL AND TRANSFORMED-CELLS [J].
DERYNCK, R ;
JARRETT, JA ;
CHEN, EY ;
EATON, DH ;
BELL, JR ;
ASSOIAN, RK ;
ROBERTS, AB ;
SPORN, MB ;
GOEDDEL, DV .
NATURE, 1985, 316 (6030) :701-705
[6]   1,25-DIHYDROXYVITAMIN-D3-DIFFERENTIATED HUMAN PROMYELOCYTIC LEUKEMIA-CELLS (HL-60) CAN KILL ANTIBODY-COATED TUMOR-CELLS (K562) [J].
ESPEVIK, T .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1985, 22 (01) :105-109
[7]   INTERLEUKIN-6 PRIMES HUMAN NEUTROPHIL AND MONOCYTE OXIDATIVE BURST RESPONSE [J].
KHARAZMI, A ;
NIELSEN, H ;
RECHNITZER, C ;
BENDTZEN, K .
IMMUNOLOGY LETTERS, 1989, 21 (02) :177-184
[8]   A NOVEL FORM OF TNF/CACHECTIN IS A CELL-SURFACE CYTO-TOXIC TRANSMEMBRANE PROTEIN - RAMIFICATIONS FOR THE COMPLEX PHYSIOLOGY OF TNF [J].
KRIEGLER, M ;
PEREZ, C ;
DEFAY, K ;
ALBERT, I ;
LU, SD .
CELL, 1988, 53 (01) :45-53
[9]   CYTOTOXIC MECHANISM OF TUMOR-NECROSIS-FACTOR-ALPHA [J].
LARRICK, JW ;
WRIGHT, SC .
FASEB JOURNAL, 1990, 4 (14) :3215-3223
[10]  
LEVY R, 1991, J IMMUNOL, V147, P3066